Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | -4.43% | -6.82% | -40.36% |
Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
Apr. 02 | HC Wainwright Adjusts Price Target on SAB Biotherapeutics to $6 From $10, Maintains Buy Rating | MT |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.